Skip to main content
Clinical Trials/ACTRN12620000142932
ACTRN12620000142932
Not yet recruiting
未知

A pilot randomized controlled trial assessing the gastrointestinal tolerability and health benefits of Soluble Tapioca Fibre in adults with healthy gastrointestinal systems: Phase One

Murdoch University0 sites60 target enrollmentFebruary 12, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Murdoch University
Enrollment
60
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 12, 2020
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Individuals without clinically diagnosed diseases with relevant effect on the gastrointestinal system or on visceral motility and agree to keep a detailed dietary for GI symptoms and stool characteristics during both phases of the study.

Exclusion Criteria

  • Individuals having constipation, defined as 0–3 stools per week for the last 6 weeks; prescription of medication for digestive symptoms such as anti\-spasmodic, laxatives, anti\-diarrheic drugs or other digestive auxiliaries, relevant history/presence of any medical disorder or intake of medication/dietary supplements potentially interfering with this trial (e.g. irritable bowel syndrome), vegetarians or vegans, intake of antibiotics within 4 weeks before the screening visit and intake of laxatives within 2 weeks before the screening visit.

Outcomes

Primary Outcomes

Not specified

Similar Trials